id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-P-0259-0003,FDA,FDA-2002-P-0259,FDA/CDER to Taro Research Institute Ltd.,Other,PAV-Petition Approval,2003-03-10T05:00:00Z,2003,3,,,2008-04-12T01:27:57Z,,0,0,090000648049c57f
FDA-2002-P-0259-0002,FDA,FDA-2002-P-0259,FDA/CDER to Taro Research Institute Ltd.,Other,PAV-Petition Approval,2002-12-06T05:00:00Z,2002,12,,,2008-04-12T01:27:57Z,,0,0,090000648049c57d
FDA-2002-P-0259-0001,FDA,FDA-2002-P-0259,FDA/DDM to Taro Research Institute Ltd.,Other,ACK-Acknowledgement Letter,2002-09-04T04:00:00Z,2002,9,,,2008-04-12T01:27:57Z,,0,0,090000648049c53a